Windlas Biotech Balance Sheet
- Market cap
- ₹2,008 crore
- P/E
- 22.5
- P/B
- 2.85
- ROE
- 14.5%
- Dividend yield
- 1.20%
- 52-week range
- ₹685.08 – ₹1,284.53
As of FY25, Windlas Biotech had total assets of ₹1,305 crore and borrowings of ₹241 crore, against shareholders' equity of ₹1,024 crore — a debt-to-equity ratio of 0.35.
Windlas Biotech balance sheet
As at each financial year end, newest first. H1 = half-year.
| Item | FY25 |
|---|---|
| Equity capital | 120 |
| Reserves | 904 |
| Borrowings | 241 |
| Other liabilities | 161 |
| Total liabilities | 1,305 |
| Fixed assets | 703 |
| Capital work in progress | 45 |
| Investments | 301 |
| Other assets | 301 |
| Total assets | 1,305 |
Balance sheet ratios
- Debt to equity
- 0.35
- Book value per share
- ₹333.86
Source: Company filings (consolidated), in ₹ crore. Data as of 9 October 2026. How this data is compiled.
Windlas Biotech balance sheet — frequently asked questions
What is the total debt of Windlas Biotech?
Windlas Biotech reported borrowings of ₹241 crore as of FY25.
What is Windlas Biotech's debt-to-equity ratio?
Based on the FY25 balance sheet, Windlas Biotech's debt-to-equity ratio is 0.35 — borrowings of ₹241 crore against equity capital and reserves of ₹1,024 crore.
What are Windlas Biotech's total assets?
Windlas Biotech's total assets were ₹1,305 crore as of FY25, including fixed assets of ₹703 crore and investments of ₹301 crore.
What is the book value per share of Windlas Biotech?
The book value per share of Windlas Biotech is ₹333.86, based on the latest reported balance sheet.
Same Data For Peers
Trade Windlas Biotech With ATS
Track WINDLAS live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.